Blog

ASLS wins the NH Tech Alliance Product of the Year award for 2025, recognizing the BioAssembly™ Platform as a breakthrough in 3D bioprinting and automated tissue manufacturing.

Discover best practices for streamlining complex organoid research with automation. Learn how Advanced Solutions Life Sciences combines robotics, software intelligence, and optimized fluidics to improve reproducibility, scalability, and experimental reliability.

In 2000, President & CEO Michael W. Golway, P.E., wrote, “Use my entrepreneurial opportunity to do something profound and positive.” 25 years later, that vision has fueled innovations like the BioAssemblyBot®, supported businesses through challenges, and advanced life-changing science. Join us in celebrating his 25-year journey — and looking ahead to a future that’s even more profound and positive.

As NAMs models such as organoids gain traction across disease modeling, drug discovery, and personalized medicine, one major challenge persists - scaling high-throughput organoid screening efficiently and reproducibly.

At Advanced Solutions Life Sciences (ASLS), we believe technology can help restore what cancer takes away - offering new possibilities for healing, confidence, and quality of life. This Breast Cancer Awareness Month, we’re proud to spotlight our global partners who are making profound and positive impacts in the fight against breast cancer, powered by our BioAssemblyBot™ platform.

Hands-Off to Organoid Assays! Manual organoid workflows often mean inconsistent results, lost time, and limited scale. Learn the top pitfalls of manual handling—and how Advanced Solutions’ BioAssemblyBot® platforms eliminate them with precision automation.

A Historic NIH Decision That Changes the Research Landscape On July 7, 2025, the National Institutes of Health (NIH) announced it will no longer issue new funding opportunities that focus exclusively on animal models. From now on, all new NIH grant announcements must include - or allow for - human-relevant research approaches, often referred to as New Approach Methodologies (NAMs).    This shift means researchers seeking NIH funding must incorporate methods like organoids,...

Hannah A. Strobel, PhD | Staff Scientist | Advanced Solutions Life Sciences  Victoria Marsh, PhD | Director, Custom Organoid Services | Molecular Devices  Maria R. Oyaga, PhD | Scientist | Core Life Analytics  Angeline Lim, PhD | Applications Scientist | Molecular Devices    Introduction:   Patient-derived organoids (PDOs) are transforming how we approach drug and therapy development, offering more predictive models of patient responses. However, effectively utilizing these c

Advanced Solutions Life Sciences is thrilled to announce the launch of BioApp Intelligence. This new software is a groundbreaking AI-driven solution designed to revolutionize laboratory automation and 3D Bioprinting. When paired with the powerful BioAssemblyBot® (BAB) Platform - the possibilities are endless. Overview BioApps Intelligence is an AI product that, coupled with the  BioAssemblyBot® (BAB) Platform, empowers laboratories to automate simple and complex laboratory w

Discover how the BioAssemblyBot 400 advances cancer therapy by automating the precise fabrication of AS1411-conjugated gold nanopartic

Discover the latest advancements in T-cell immunotherapies for cancer treatment.

Discover how single cell dispensing is transforming life sciences research. The BioAssemblyBot® Hand | SCD automates precise dispensing of individual cells, boosting efficiency and reproducibility for gene editing, clonal expansion, antibody development, and more. Integrated with BioApps™, this solution streamlines workflows and accelerates impactful discoveries in modern labs.

Advanced Solutions Life Sciences (ASLS) and Epson Robots have revolutionized biotechnology with the BioAssemblyBot (BAB), a platform that...

Advanced Solutions introduces the Single Cell Dispense BAB Hand. Paired with BioApps(TM), the Single Cell Dispense BAB Hand enables a workflow that improves the efficiency and accuracy of single cell analysis. The Single Cell Dispense BAB Hand works on all BAB Models, including the BAB500, BAB400, and BAB200.

This blog post discusses a study conducted by Advanced Solutions using a 3D in vitro model

Tissue organoids, also known as "mini organs," possess vast potential as tools for various applications, such as disease modeling, drug screening, and tissue engineering. To effectively imitate the native tissue environment, it is essential to integrate a microvasculature with the parenchyma and stroma.

Turnkey platform integrates flexible robotic automation with high-content imaging of complex 3D cellular models.

Organoids and spheroids are proving to be useful tools in drug target discovery and screening.

To begin exploring the utility of the model for NAFLD/NASH, liver tissues were exposed to a high fat medium (HFM) comprised of a base medium supplemented with glucose (25mM), palmitic acid (45μM), and sodium oleate (65μM).

October is Breast Cancer Awareness Month and BAB is empowering women with a new type of breast prosthetics through pioneering research.